RE
Royal Emerald Pharmaceuticals
Royal Emerald Pharmaceuticals develops non-addictive alternative medications targeting PTSD and related health issues through proprietary formulations. The company aims to provide effective treatment options that minimize dependency risks associated with traditional pharmaceuticals.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$17MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Royal Emerald Pharmaceuticals develops non-addictive alternative medications targeting PTSD and related health issues through proprietary formulations. The company aims to provide effective treatment options that minimize dependency risks associated with traditional pharmaceuticals.